Clinical Trials Sponsored by FNRS (Belgium)

Total 846 results

Institute of Tropical Medicine, Belgium

Completed

Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru

Malaria
Virometix
Center of Vaccinology, Ghent, Belgium (CEVAC); Expert Clinical Services Organization...

Completed

Phase 1 Study to Evaluate the Safety and Immunogenicity of a Candidate Vaccine Against Respiratory Syncytial Virus

Acute Bronchiolitis Due to Respiratory Syncytial Virus

Belgium
University Hospital, Ghent
VZW kinderkankerfonds, Belgium

Recruiting

Multidisciplinary Rehabilitation of Children and Adolescents After Acute Cancer Treatment

Rehabilitation | Exercise Therapy | Cancer Survivors

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Unknown

Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas

Emergencies | Covid19 | Hypoxemic Respiratory Failure

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Double Trunk Mask and Standard Nasal Cannula During Acute Hypoxia

Hypoxia

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Effect of a Modified Oxygen Mask Associated to Nasal Prongs During a High Flow Oxygenation Method

Oxygen Inhalation Therapy

Belgium
Laboratory of Movement, Condorcet, Tournai, Belgium

Completed

Does Obesity Influence Women Cardiorespiratory Fitness and Daily Physical Activities? (ACTIVOB) (ACTIVOB)

Obesity

Belgium
University Ghent
Special Research Fund, Belgium

Completed

Effect Study of an Eccentric Training Program and Stretching for Patients With Chronical Rotator Cuff Tendinopathy

Chronical Rotator Cuff Tendinopathy

Belgium
University Ghent
Fund for Scientific Research, Flanders, Belgium; International Centre for Reproductive...

Completed

Intimate Partner Violence and Pregnancy, a Perinatal Care Intervention Study (MOM)

Intimate Partner Violence

Belgium
Centre Oscar Lambret
Anticancer Fund, Belgium

Completed

Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas (FLUVABREX)

Glioma

France
Sciensano
Institute of Tropical Medicine, Belgium

Completed

COVID-19 Among Healthcare Workers in Belgian Hospitals (COVHECBEHO)

COVID-19 | SARS-CoV-2

Belgium
Yale University
Janssen Pharmaceutica N.V., Belgium

Completed

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Diabetes Mellitus | Schizophrenia | Bipolar Disorder
Université Libre de Bruxelles
Fonds National de la Recherche Scientifique; Belgium: Belgian Federal Science...

Completed

Sensory Stimulation Effect on Movement Speed in Patients With Parkinson Disease

Parkinson Disease

Belgium
iTeos Belgium SA
GlaxoSmithKline; iTeos Therapeutics

Recruiting

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (TIG-006)

Melanoma | Head and Neck Cancer | Lung Cancer | Advanced Cancer

Spain, Italy, France, United States, United Kingdom, Belgium
Institute of Tropical Medicine, Belgium
Sciensano

Completed

Development and Implementation of an HIV-testing Intervention for Primary Care in Belgium

HIV Infections

Belgium
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Ovarian Cancer

Russian Federation
NewVac LLC
Janssen Pharmaceutica N.V., Belgium

Completed

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Epithelial Ovarian Cancer | Non-small Cell Lung Cancer

Russian Federation
Scalab CNRS 9193

Unknown

Orthophonic and / or Proprioceptive Treatment of Developmental Dyslexia. (Pro-Pho-Dys)

Developmental Dyslexia

France
Institute of Tropical Medicine, Belgium
University Ghent; Nutrition Third World, Belgium; Flemish Interuniversity Council...

Completed

Effect of Prenatal Nutritional Supplementation on Birth Outcome in Hounde District, Burkina Faso (MISAME2)

Low Birth Weight | Intrauterine Growth Retardation

Burkina Faso
Bellicum Pharmaceuticals

Terminated

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Hemoglobinopathies | Hemophagocytic Lymphohistiocytosis | Metabolic Disorders | Primary Immune Deficiency Disorders | Inherited Bone Marrow Failure Syndrome

United States
Bellicum Pharmaceuticals

Terminated

Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant

Lymphoma, Non-Hodgkin | Acute Lymphoblastic Leukemia | Primary Immunodeficiency | Anemia, Sickle Cell | Hemoglobinopathies | Fanconi Anemia | Anemia, Aplastic | Myelodysplastic Syndrome | Thalassemia | Cytopenia | Diamond Blackfan Anemia | Osteopetrosis | Leukemia, Acute Myeloid (AML), Child

United Kingdom, Italy
Bellicum Pharmaceuticals

Terminated

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Primary Immunodeficiency | Anemia, Sickle Cell | Hemoglobinopathies | Fanconi Anemia | Anemia, Aplastic | Thalassemia | Cytopenia | Diamond Blackfan Anemia | Leukemia, Acute Myeloid (AML), Child

Italy
Bellicum Pharmaceuticals

Withdrawn

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphomas | Other High-risk Hematological Malignancies
Bellicum Pharmaceuticals

Withdrawn

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Hematologic Malignancies

United States
Bellicum Pharmaceuticals

No longer available

BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Hurler Syndrome | Inborn Errors of Metabolism | Metachromatic Leukodystrophy | Inherited Metabolic Disorder | Lysosomal Storage Disorder

United States
Bellicum Pharmaceuticals

Suspended

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein Overexpression

United States
Bellicum Pharmaceuticals

Active, not recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Lymphoma | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia

United States
Bellicum Pharmaceuticals

Active, not recruiting

Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant

Hematologic Malignancy

Italy
Bellicum Pharmaceuticals

Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

Lymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Anemia, Aplastic | Primary Immune Deficiency Disorder | Cytopenia | Osteopetrosis | Leukemia, Acute Myeloid (AML), Child | Hemoglobinopathy in Children

United States
Bellicum Pharmaceuticals

Completed

Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer

Castrate Resistent Prostate Cancer

United States
Bellicum Pharmaceuticals

Terminated

Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Uveal Melanoma

United States
Bellicum Pharmaceuticals

Terminated

Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (THRIVE)

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Bellicum Pharmaceuticals

Suspended

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

United States
Bellicum Pharmaceuticals

Active, not recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Hematologic Neoplasms | Multiple Myeloma

United States
ANRS, Emerging Infectious Diseases

Not yet recruiting

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. (CABOPrEP)

Prevention

France
ANRS, Emerging Infectious Diseases

Recruiting

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia (HEPEDIAC)

HCV Infection

Cambodia
ANRS, Emerging Infectious Diseases

Recruiting

Aging With HIV and Neurocognitive Decline, a Follow-up Study (AgingHAND)

HIV Infections

France
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 Epidemic (RESPOND-FR)

Quality of Life | Psychological Distress | Psychosocial Intervention

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns (IPOP)

Mother to Child HIV Transmission
ANRS, Emerging Infectious Diseases

Recruiting

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Covid19 | SARS-CoV Infection

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection

HIV I Infection
ANRS, Emerging Infectious Diseases

Completed

Health and Migration Trajectories of Housekeepers in Bamako (2DM2K)

HIV Infections | Hepatitis B | Hepatitis C | Tuberculosis | STIs | Sex Behavior

Mali
ANRS, Emerging Infectious Diseases

Completed

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (DRIVE-C)

Hepatitis C | Viral Hepatitis C | Drug Use

Vietnam
ANRS, Emerging Infectious Diseases

Terminated

Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial (AMEP-EHVA T02)

HIV Seropositivity

Switzerland
ANRS, Emerging Infectious Diseases

Completed

A Community-based Intervention Among Active Drug Users in Montpellier (ICONE)

Drug Use | HCV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire (PRECO-CI)

HIV Infection

Côte D'Ivoire
ANRS, Emerging Infectious Diseases

Completed

Systematic Empirical vs. Test-guided Anti-TB Treatment Impact in Severely Immunosuppressed HIV-infected Adults Initiating ART With CD4 Cell Counts <100/mm3 (STATIS)

HIV-1 Infection

Vietnam, Cambodia, Côte D'Ivoire, Uganda
ANRS, Emerging Infectious Diseases

Completed

Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety

Growth and Development

Burkina Faso, South Africa, Uganda, Zambia
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Evaluation of Raltegravir During the Third Trimester of Pregnancy (ANRS 160 RalFE)

HIV-1 Infection | PREGNANCY

France

Clinical Trials Sponsored by FNRS (Belgium)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations